Tech Company Financing Transactions

Ruxton Pharmaceuticals Funding Round

Ruxton Pharmaceuticals, operating out of Lutherville, secured $3.6 million from Domain Associates.

Transaction Overview

Announced On
6/30/2007
Transaction Type
Venture Equity
Amount
$3,570,000
Round
Undisclosed
Investors

Domain Associates (Nicole Vitullo)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
2330 W. Joppa Road 355
Lutherville, MD 21093
USA
Email Address
Overview
Ruxton Pharmaceuticals is an emerging pharmaceutical company that has been formed to discover, develop and market drugs for the treatment of neurodegenerative diseases.
Profile
Ruxton Pharmaceuticals LinkedIn Company Profile
Social Media
Ruxton Pharmaceuticals Company Twitter Account
Company News
Ruxton Pharmaceuticals News
Facebook
Ruxton Pharmaceuticals on Facebook
YouTube
Ruxton Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Richard Chipkin
  Richard Chipkin LinkedIn Profile  Richard Chipkin Twitter Account  Richard Chipkin News  Richard Chipkin on Facebook
Chief Scientific Officer
Rita Sattler
  Rita Sattler LinkedIn Profile  Rita Sattler Twitter Account  Rita Sattler News  Rita Sattler on Facebook
Founder
Jeffrey Rothstein
  Jeffrey Rothstein LinkedIn Profile  Jeffrey Rothstein Twitter Account  Jeffrey Rothstein News  Jeffrey Rothstein on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/30/2007: Luxim venture capital transaction
Next: 6/30/2007: NEHP venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to record every notable VC transaction. All VC database entries on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary